| FRANKLIN BIOTECHNOLOGY DISCOVERY A (ACC) CHF-H1 | BIOTECNOLOGÍA | 25,51% | 58,47% | 28,78% | 50,75% |
| BGF EMERGING MARKETS EQUITY INCOME D2 EUR | RVI EMERGENTES | 25,49% | 46,81% | 41,14% | · |
| FAST-EMERGING MARKETS FUND A-PF-ACC-USD | RVI EMERGENTES | 25,49% | 59,11% | 38,54% | 87,64% |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND I USD HEDGED | RVI JAPÓN VALOR | 25,49% | 108,86% | 233,04% | 225,25% |
| PRIVILEDGE - JPMORGAN EUROZONE EQUITY (EUR) M CAP | RV EURO | 25,49% | 64,32% | 101,91% | · |
| RBC FUNDS (LUX)-ASIA EX-JAPAN EQUITY FUND O CAP USD | RVI ASIA EX-JAPÓN | 25,49% | 44,97% | 31,34% | 113,08% |
| AMUNDI FUNDS LATIN AMERICA EQUITY A USD (C) | RVI LATINOAMÉRICA | 25,48% | 35,56% | 81,71% | 88,24% |
| MAN JAPAN COREALPHA EQUITY I H GBP NET-DIS A | RVI JAPÓN | 25,47% | 111,32% | · | 92,41% |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY I EUR | RVI EMERGENTES | 25,46% | 57,29% | · | 141,59% |
| JPM EUROPE EQUITY PLUS C (ACC) EUR | RVI EUROPA | 25,44% | 69,48% | 117,28% | · |
| PRIVILEDGE - MONETA BEST OF FRANCE (EUR) I CAP | RV EURO | 25,44% | 27,58% | 62,12% | · |
| BESTINVER TORDESILLAS SICAV - IBERIA LONG-SHORT Z EUR CAP | GESTIÓN ALTERNATIVA | 25,43% | 29,59% | 31,53% | · |
| ISHARES MSCI CHINA UCITS ETF USD (ACC) | RVI CHINA | 25,43% | 44,58% | -9,26% | · |
| MAN SYSTEMATIC EMERGING MARKETS EQUITY I GBP | RVI EMERGENTES | 25,43% | 55,95% | · | · |
| SCHRODER ISF EUROPEAN VALUE C ACC EUR | RVI EUROPA VALOR | 25,42% | 47,46% | 114,42% | 92,83% |
| HSBC GIF ASIA EX JAPAN EQUITY ACO EUR | RVI ASIA EX-JAPÓN | 25,40% | 45,21% | 0,49% | 55,19% |
| PERINVEST (LUX) SICAV-ASIA DIVIDEND EQUITY A | RVI ASIA EX-JAPÓN | 25,39% | · | · | · |
| PRIVILEDGE - MONETA BEST OF FRANCE (EUR) M CAP | RV EURO | 25,39% | 27,30% | 61,35% | · |
| PRIVILEDGE - MONETA BEST OF FRANCE (EUR) N CAP | RV EURO | 25,39% | 27,27% | 61,42% | · |
| SANTANDER EUROPEAN DIVIDEND AU CAP | RVI EUROPA VALOR | 25,39% | 45,16% | 48,24% | 42,00% |
